Close Menu
Home » Meridian Bioscience Dx Revenue Woes Likely to Continue Through 2020 Despite Promising Integration of GenePOC

Meridian Bioscience Dx Revenue Woes Likely to Continue Through 2020 Despite Promising Integration of GenePOC

Jul 31, 2019
|
Madeleine Johnson
Premium

NEW YORK – In spite of the company's recent acquisition of GenePOC in an effort to fortify its diagnostics business, Meridian Bioscience's CEO said on Tuesday that it could be more than a year before that business reverses its slide.

On Tuesday, the Cincinnati-based firm announced a 6 percent drop in revenues year-over-year for its fiscal third quarter, with a 9 percent decline in its diagnostics business, driven primarily by a 21 percent decline in molecular diagnostics.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

For Scientific Talent

Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.

Agency Pick Worries Brazilian Researchers

ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.

Speedy Work

The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.

PLOS Papers Include Greenlander BMI GWAS, Metabolic MicroRNA Marker Search, More

In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more. 

Jan
28
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of FLT3 and CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

Feb
05
Featured Webinar

Development of a Novel Multiplex Assay: A Partnership Case Study

Sponsored by
LGC

This webinar will provide a behind-the-scenes look at the collaborative development of a novel multiplex assay to speed detection of mosquito-borne illness in the clinical setting.

Feb
25
Featured Webinar

Long-Read Sequencing of Human Transcription Provides Insights into Metastatic Cancer

Sponsored by
Loop Genomics

This webinar will discuss a study that used long-read transcriptome sequencing to explore the distribution of isoforms in colon cancer samples and their metastasis counterparts. 

Feb
26
Featured Webinar

Transformation of the Lab to Fight Genetic Illnesses in the Amish and Mennonite Populations

Sponsored by
Autogen

This webinar will explain how the Clinic for Special Children in Strasburg, Pennsylvania, has transformed its DNA workflows to improve the diagnosis and treatment of genetic illnesses that are prevalent in the pediatric population of its community.

What's Popular?

In PCR

  1. Natera Sues ArcherDx for Infringement of New Target Amplification Patent

  2. Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

    Premium

  3. CDC Provides Test Protocol for Novel Coronavirus, Preps Kits for Local Use

  4. UK Newborn Trial to Assess PCR Test for Antibiotic-Induced Hearing Loss

  5. Co-Diagnostics Selling $5M of Shares

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.